Appropriate clinical management of women taking valproate.
Piontek
C M
CM
Case Western Reserve University, Cleveland, Ohio, USA.
Wisner
K L
KL
D000328:Adult; D000367:Age Factors; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D001835:Body Weight; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D006801:Humans; D017588:Hyperandrogenism / Q000139:chemically induced; D007333:Insulin Resistance; D008599:Menstruation Disturbances / Q000139:chemically induced; D011085:Polycystic Ovary Syndrome / Q000139:chemically induced; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D012737:Sex Factors; D014635:Valproic Acid / Q000009:adverse effects* / Q000627:therapeutic use
D000927:Anticonvulsants; D014635:Valproic Acid